1672
V. Molteni et al.
PAPER
as eluent with run time of 6 min unless otherwise specified. Analyt-
ical GC experiments utilized an Agilent 6890, Agilent 7673 injec-
tor, and Agilent 6890 MSD detector. Analytical GC columns were
J & W Scientific (5% diphenyl, 95% dimethyl polysiloxane; length:
29 m; diameter: 250.00 m, film thickness: 0.25 m). The column
used was 8.17 min long with a flow rate of 19.2 mL/min. Tempera-
ture profile was: initial temp 70 °C for 1 min, 115 °C @ 45 °C/min
for 1 min, 175 °C @ 40 °C/min for 1.5 min, 300 °C @ 30 °C/min
for 4.17 min, the oven remained at 300 °C for 0.5 min. Retention
times for both LC/MS and GC/MS are reported with the % area of
the peak. NMR spectra were obtained using either Varian 300 MHz
or 400 MHz instruments. Chemical shifts are reported in ppm rela-
tive to internal solvent signals. Coupling constants are reported in
Hertz (Hz). Carbon spectra are proton spin decoupled and observed
multiplicities are indicated for fluorine containing molecules.
MS (ESI): m/z = 249.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C13H10F2N2O, 249.0839;
found, 249.0842.
1-(3,5-Dimethylphenyl)-1,5,6,7-tetrahydro-4H-indazol-4-one
(4b-4)
Yield: 71% (213 mg); mp 120–121 °C; HPLC tR 3.27 min (100%);
GC/MS tR 6.62 min (100%).
1H NMR (300 MHz, CDCl3): = 7.97 (s, 1 H, CH), 7.03 (s, 2 H,
Ar), 6.98 (s, 1 H, Ar), 2.89 (t, 2 H, J = 5.7 Hz, CH2CO), 2.47 (t, 2
H, J = 5.7 Hz, CH2C=), 2.31 (s, 6 H, 2 CH3), 2.09 (m, 2 H,
CH2CH2CH2).
13C NMR (300 MHz, CDCl3): = 193.50, 149.19, 139.53, 138.53,
138.43, 130.15, 121.59, 120.33, 38.13, 23.84, 23.48, 21.51.
MS (ESI): m/z = 241.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C15H16N2O, 241.1341; found,
Bicyclic 4-Acylpyrazoles 4b from Enaminoketones; General
Procedure (Table 2)
In a Smith process vial, the enaminoketone1 1a–c (1.25 mmol) was
dissolved in H2O (2.5 mL) and the corresponding hydrazine
monochloride was added (1.25 mmol), followed by AcOH (3.25
mmol). The vial was sealed and submitted to microwave irradiation
for 120 s at 200 °C using the Smith Synthesizer. Upon cooling and
stirring with a spatula, the product precipitated from the reaction
mixture. It was filtered, washed with water and hexane, and dried.
241.1341.
1-(6-Methyl-4-trifluoromethylpyridin-2-yl)-1,5,6,7-tetrahydro-
4H-indazol-4-one (4b-5)
Yield: 65% (239 mg); mp 121–122 °C; HPLC tR 3.63 min (82%);
GC/MS tR 5.83 min (100%).
1H NMR (300 MHz, CDCl3): = 7.97 (s, 1 H, CH), 7.94 (s, 1 H,
Ar), 7.21 (s, 1 H, Ar), 3.40 (t, 2 H, J = 6.3 Hz, CH2CO), 2.56 (s, 3
H, CH3), 2.46 (t, 2 H, J = 6.0 Hz, CH2C=), 2.12 (m, 2 H,
CH2CH2CH2).
13C NMR (300 MHz, CDCl3): = 193.96, 159.20, 153.06, 151.49,
141.5 (q), 139.43, 124.52, 122.03, 120.89, 117.06 (d), 108.8 (q),
38.14, 25.46, 24.48, 23.60.
1-(2,4-Dimethylphenyl)-1,5,6,7-tetrahydro-4H-indazol-4-one
(4b-1)
Yield: 92% (276 mg); mp 127–128 °C; HPLC tR 3.05 min (95%);
GC/MS tR 6.3 min (100%).
1H NMR (300 MHz, CDCl3): = 7.94 (s, 1 H, CH), 7.06 (s, 1 H,
Ar), 7.01 (s, 2 H, Ar), 2.53 (t, 2 H, J = 6.3 Hz, CH2CO), 2.42 (t,
2 H, J = 6.3 Hz, CH2C=), 2.28 (s, 3 H, CH3), 2.03 (m, 2 H,
CH2CH2CH2), 1.95 (s, 3 H, CH3).
MS (ESI): m/z = 296.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C14H12F3N3O, 296.1011;
13C NMR (300 MHz, CDCl3): = 193.44, 150.79, 140.09, 138.08,
135.24, 134.73, 132.15, 127.59, 127.01, 119.29, 38.19, 23.66,
21.99, 21.40, 17.52.
MS (ESI): m/z = 241.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C15H16N2O, 241.1341; found,
found, 296.1008.
1-Pyridin-2-yl-1,5,6,7-tetrahydro-4H-indazol-4-one (4b-6)
Yield: 85% (226 mg); mp 125–126 °C; HPLC tR 2.60 min (92%);
GC/MS tR 6.0 min (100%).
1H NMR (300 MHz, CDCl3): = 8.38 (m, 1 H, CH), 7.97 (s, 1 H,
Ar), 7.89 (m, 1 H, Ar), 7.78 (m, 1 H, Ar), 7.18 (m, 1 H, Ar), 3.40 (t,
2 H, J = 6.3 Hz, CH2CO), 2.46 (t, 2 H, J = 5.7 Hz, CH2C=), 2.11 (m,
2 H, CH2CH2CH2).
13C NMR (300 MHz, CDCl3): = 194,15, 152.89, 151.14, 147.97,
139.02, 138.98, 122.32, 121.65, 115.85, 38.24, 25.25, 23.69.
MS (ESI): m/z = 214.2 [M + H]+.
241.1335.
1-Phenyl-1,5,6,7-tetrahydro-4H-indazol-4-one (4b-2)
Yield: 86% (228 mg); mp 139–140 °C (Lit.1a mp 140 °C); HPLC tR
2.66 min (94%); GC/MS tR 6.0 min (100%).
1H NMR (300 MHz, CDCl3): = 7.99 (s, 1 H, CH), 7.43 (m, 5 H,
Ar), 2.90 (t, 2 H, J = 6.3 Hz, CH2CO), 2.48 (t, 2 H, J = 6.3 Hz,
CH2C=), 2.09 (m, 2 H, CH2CH2CH2).
HRMS (ESI): m/z [M + H]+ calcd for C12H11N3O, 214.098; found,
13C NMR (300 MHz, CDCl3): = 193.45, 149.25, 138.69, 138.67,
129.63, 128.47, 123.80, 120.54, 38.10, 23.83, 23.46.
214.0984.
1-Cyclohexyl-1,5,6,7-tetrahydro-4H-indazol-4-one (4b-7)
Yield: 79% (215 mg); mp 87–88 °C; HPLC tR 2.77 min (100%);
GC/MS tR 5.98 min (100%).
MS (ESI): m/z = 213.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C13H12N2O, 213.1028; found,
213.1029.
1H NMR (300 MHz, CDCl3): = 7.81 (s, 1 H, CH=N), 3.87 (m, 1
H, CHN), 2.75 (t, 2 H, J = 6.0 Hz, CH2CO), 2.40 (t, 2 H, J = 6.0 Hz,
CH2C=), 2.10 (m, 2 H, CH2CH2CH2), 1.86 (m, 6 H, CH2 cyclohex-
yl), 1.64 (m, 2 H, CH2 cyclohexyl), 1.29 (m, 2 H, CH2 cyclohexyl).
13C NMR (300 MHz, CDCl3): = 193.42, 148.09, 137.04, 118.91,
58.75, 38.26, 32.74, 25.69, 25.26, 23.48, 21.49.
MS (ESI): m/z = 219.2 [M + H]+.
HRMS (ESI): m/z [M + H]+ calcd for C13H18N2O, 219.1497; found,
1-(2,4-Difluorophenyl)-1,5,6,7-tetrahydro-4H-indazol-4-one
(4b-3)
Yield: 83% (257 mg); mp 121–122 °C; HPLC tR 2.74 min (93%);
GC/MS tR 5.6 min (100%).
1H NMR (300 MHz, CDCl3): = 7.01 (s, 1 H, CH), 7.46 (m, 1 H,
Ar), 6.96 (m, 2 H, Ar), 2.70 (t, 2 H, J = 5.4 Hz, CH2CO), 2.47 (t, 2
H, J = 6 Hz, CH2C=), 2.10 (m, 2 H, CH2CH2CH2).
13C NMR (300 MHz, CDCl3): = 193.42, 164.79 (d), 161.43 (d),
158.28 (d), 154.91 (d), 151.86, 139.30, 129.76 (d), 122.93 (d),
120.34, 112.57 (d), 105.41 (t), 38.07, 23.54, 21.99.
219.1494.
Synthesis 2002, No. 12, 1669–1674 ISSN 0039-7881 © Thieme Stuttgart · New York